MYCN and neuroblastoma: To validate these findings at the protein level, we performed immunoprofiling using multiplex NanoString digital spatial profiling technology on a neuroblastoma tissue array containing 33 independent neuroblastoma tumors of which 9 were MYCN.A and 24 were MYCN.NA (Wei et al., 2018).